Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

120 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Nectin-4 Positivity in Genitourinary Malignancies: A Systematic Review.
Crupi E, Costa de Padua T, Marandino L, Fallara G, Pederzoli F, Cimadamore A, Goetz EC, Cigliola A, Patané DA, Mercinelli C, Tateo V, Salonia A, Briganti A, Montorsi F, Meeks JJ, Spiess PE, Alhalabi O, Gao J, Kamat AM, Grivas P, Necchi A, Raggi D. Crupi E, et al. Among authors: marandino l. JCO Precis Oncol. 2024 Dec;8:e2400470. doi: 10.1200/PO-24-00470. Epub 2024 Dec 3. JCO Precis Oncol. 2024. PMID: 39626158 Review.
Neoadjuvant and Adjuvant Immune-based Approach for Renal Cell Carcinoma: Pros, Cons, and Future Directions.
Marandino L, Campi R, Amparore D, Tippu Z, Albiges L, Capitanio U, Giles RH, Gillessen S, Kutikov A, Larkin J, Motzer RJ, Pierorazio PM, Powles T, Roupret M, Stewart GD, Turajlic S, Bex A. Marandino L, et al. Eur Urol Oncol. 2024 Sep 25:S2588-9311(24)00211-6. doi: 10.1016/j.euo.2024.09.002. Online ahead of print. Eur Urol Oncol. 2024. PMID: 39327187 Free article. Review.
Adjuvant pembrolizumab prolongs overall survival in renal cell carcinoma at high-risk of recurrence after nephrectomy. Can we do better than this?
Ciccarese C, Mollica V, Marandino L, Palumbo C, Campi R, Amparore D; EAU Young Academic Urologists (YAU) Renal Cancer Working Group. Ciccarese C, et al. Among authors: marandino l. Minerva Urol Nephrol. 2024 Oct;76(5):540-544. doi: 10.23736/S2724-6051.24.06114-7. Minerva Urol Nephrol. 2024. PMID: 39320246 Free article. No abstract available.
Frailty and Renal Cell Carcinoma: Integration of Comprehensive Geriatric Assessment into Shared Decision-making.
Pecoraro A, Testa GD, Marandino L, Albiges L, Bex A, Capitanio U, Cappiello I, Masieri L, Mir C, Roupret M, Serni S, Ungar A, Rivasi G, Campi R. Pecoraro A, et al. Among authors: marandino l. Eur Urol Oncol. 2024 Sep 20:S2588-9311(24)00210-4. doi: 10.1016/j.euo.2024.09.001. Online ahead of print. Eur Urol Oncol. 2024. PMID: 39306584 Free article. Review.
Association between health-related quality-of-life results, outcomes of efficacy and drug approvals: a meta-research study of randomized phase III trials in oncology.
Paratore C, Zichi C, Schiavone R, Caglio A, Gamba T, Bombaci S, Vellani G, Marandino L, Perrone F, Di Maio M. Paratore C, et al. Among authors: marandino l. ESMO Open. 2024 Aug;9(8):103654. doi: 10.1016/j.esmoop.2024.103654. Epub 2024 Jul 26. ESMO Open. 2024. PMID: 39067259 Free PMC article.
Thermal ablation for T1b renal cancer: an "I wish I could, but I cannot?".
Bertolo R, Amparore D, Muselaers S, Marchioni M, Wu Z, Campi R, Antonelli A; EAU Young Academic Urologists (YAU) - Renal Cancer Working Group. Bertolo R, et al. Minerva Urol Nephrol. 2024 Apr;76(2):254-259. doi: 10.23736/S2724-6051.24.05842-7. Minerva Urol Nephrol. 2024. PMID: 38742559 Free article. No abstract available.
Preoperative risk calculator for the probability of completing nephron sparing for kidney cancer.
Cei F, Larcher A, Rosiello G, Basile G, Musso G, Re C, Fallara G, Belladelli F, Brembilla G, Guazzarotti G, De Cobelli F, Marandino L, Necchi A, Briganti A, Salonia A, Bertini R, Montorsi F, Capitanio U. Cei F, et al. Among authors: marandino l. Urol Oncol. 2024 Aug;42(8):247.e21-247.e27. doi: 10.1016/j.urolonc.2024.01.029. Epub 2024 Apr 21. Urol Oncol. 2024. PMID: 38644109
120 results